Liping Liang

机构：Mongolian University of Science and Technology, Xinjiang Medical University, Fudan University, Guangzhou First People's Hospital, Changzhou University, Huashan Hospital, South China University of Technology, Guangzhou Medical University · ORCID：0009-0001-5638-5881

发表论文 51 篇 · 总被引 1928 次 · h-index 21

代表论文

• Liensinine alleviates high fat diet (HFD)-induced non-alcoholic fatty liver disease (NAFLD) through suppressing oxidative stress and inflammation via regulating TAK1/AMPK signaling (2022 · International Immunopharmacology · 被引 57)
• Poor prognostic and staging value of tumor deposit in locally advanced rectal cancer with neoadjuvant chemoradiotherapy (2019 · Cancer Medicine · 被引 47)
• Harnessing Sulforaphane Potential as a Chemosensitizing Agent: A Comprehensive Review (2024 · Cancers · 被引 39)
• Plasma cysteine/cystine redox couple disruption in animal models of temporal lobe epilepsy (2016 · Redox Biology · 被引 35)
• Gut microbiota and their influence in brain cancer milieu (2025 · Journal of Neuroinflammation · 被引 23)
• Unveiling the Power of Gut Microbiome in Predicting Neoadjuvant Immunochemotherapy Responses in Esophageal Squamous Cell Carcinoma (2024 · Research · 被引 20)